Literature DB >> 15122746

Gut flora-based therapy in liver disease? The liver cares about the gut.

Steven F Solga, Anna Mae Diehl.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15122746     DOI： 10.1002/hep.20220

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight.

Authors:  Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-09

Review 2.  Gut microbiota and hepatic encephalopathy.

Authors:  Radha K Dhiman
Journal:  Metab Brain Dis       Date:  2013-03-06       Impact factor: 3.584

3.  Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy.

Authors:  Kai O Lindros; Harri A Järveläinen
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  Bio-ecological control of chronic liver disease and encephalopathy.

Authors:  Stig Bengmark
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

5.  The effect of a probiotic on hepatic steatosis.

Authors:  Steven F Solga; Gillian Buckley; Jeanne M Clark; Alena Horska; Anna Mae Diehl
Journal:  J Clin Gastroenterol       Date:  2008 Nov-Dec       Impact factor: 3.062

6.  Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.

Authors:  Kazuya Okushin; Yu Takahashi; Nobutake Yamamichi; Takeshi Shimamoto; Kenichiro Enooku; Hidetaka Fujinaga; Takeya Tsutsumi; Yoshizumi Shintani; Yoshiki Sakaguchi; Satoshi Ono; Shinya Kodashima; Mitsuhiro Fujishiro; Kyoji Moriya; Hiroshi Yotsuyanagi; Toru Mitsushima; Kazuhiko Koike
Journal:  BMC Gastroenterol       Date:  2015-02-19       Impact factor: 3.067

Review 7.  Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

8.  Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Authors:  Yvonne Ritze; Gyöngyi Bárdos; Anke Claus; Veronika Ehrmann; Ina Bergheim; Andreas Schwiertz; Stephan C Bischoff
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.